Skip to main content

Table 2 Number of cancers by prostate specific antigen (PSA) level

From: A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

Total PSA (ng/ml)

No cancer detected

Low-grade cancer

High-grade cancer

2.6 to 4.0

241 (84%)

43 (15%)

3 (1%)

4.1 to 10.0

274 (74%)

79 (21%)

18 (5%)

10.1 to 20.0

27 (50%)

18 (33%)

9 (17%)

>20.0

6 (21%)

12 (43%)

10 (36%)

  1. Cancers with biopsy Gleason score 7 and higher were considered high grade.